Crossmark

Hemoglobin Beth Israel [HBB:c.308A>G (p.Asn103Ser)]: an ultra-rare, low oxygen-affinity, non-methemoglobinemic hemoglobin diagnosed on targeted resequencing as cause of dominantly inherited benign cyanosis

Crossref DOI link: https://doi.org/10.1007/s00277-022-04989-3

Published Online: 2022-10-01

Published Print: 2022-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Singh, Namrata

Jamwal, Manu

Sharma, Ritika

Murgai, Pooja

Chhabra, Sanjeev

Hira, Jasbir Kaur

Das, Reena

Sharma, Prashant https://orcid.org/0000-0003-4741-3403
License Information

Text and Data Mining valid from 2022-10-01

Version of Record valid from 2022-10-01
More Information

Article History

Received: 30 August 2022

Accepted: 19 September 2022

First Online: 1 October 2022

Declarations

:

: This research complied with all relevant national regulations, institutional policies, and is in accordance with the tenets of the Helsinki Declaration (as revised in 2013). It was approved by the authors’ Institutional Review Board.

: Informed consent was taken from the family to participate in the study.

: Informed consent was taken from the family to participate in the study.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below